软骨寡聚基质蛋白(COMP)重组蛋白
Recombinant Cartilage Oligomeric Matrix Protein (COMP)
MED; EDM1; EPD1; PSACH; THBS5; TSP-5; Pseudoachondroplasia,Epiphyseal Dysplasia 1,Multiple; Thrombospondin 5
- 编号RPB197Mu02
- 物种Mus musculus (Mouse，小鼠) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量16.1kDa
- 实际分子量18kDa(差异分析请参阅说明书)
- 片段与标签Thr40~Asn180 (Accession # Q9R0G6) with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 90%
- 等电点6.77
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 998 ¥ 2496 ¥ 4992 ¥ 14976 ¥ 37440
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
SDS-PAGE图
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPB197Mu02 | 软骨寡聚基质蛋白(COMP)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB197Mu03 | 软骨寡聚基质蛋白(COMP)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB197Mu04 | 软骨寡聚基质蛋白(COMP)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB197Mu01 | 软骨寡聚基质蛋白(COMP)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB197Mu01 | 软骨寡聚基质蛋白(COMP)多克隆抗体 | WB; IHC; ICC; IP. |
| PAB197Mu04 | 软骨寡聚基质蛋白(COMP)多克隆抗体 | WB; IHC; ICC; IP. |
| PAB197Mu03 | 软骨寡聚基质蛋白(COMP)多克隆抗体 | WB; IHC; ICC; IP. |
| PAB197Mu02 | 软骨寡聚基质蛋白(COMP)多克隆抗体 | WB; IHC; ICC; IP. |
| LAB197Mu71 | 软骨寡聚基质蛋白(COMP)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAB197Mu22 | 软骨寡聚基质蛋白(COMP)单克隆抗体 | WB. |
| MAB197Mu21 | 软骨寡聚基质蛋白(COMP)单克隆抗体 | WB; IHC; ICC; IP. |
| SEB197Mu | 软骨寡聚基质蛋白(COMP)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB197Mu | 软骨寡聚基质蛋白(COMP)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
| KSB197Mu01 | 软骨寡聚基质蛋白(COMP)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
| 杂志 | 参考文献 |
| Chinese Medical Journal | Genetic analysis and serum level of cartilage oligomeric matrix protein in patients with pseudoachondroplasia [CMJ: 201082337960590] |
| BioMed Research International | Decreased Plasma COMP and Increased Plasma CTX-II Levels in a Chinese Pseudoachondroplasia Family with Novel COMP Mutation [pubmed:29104872] |
| Molecular Medicine Reports | Mori Folium water extract alleviates articular cartilage damages and inflammatory responses in monosodium iodoacetate‑induced osteoarthritis rats [pubmed:29067461] |
| Archives of Rheumatology | Cartilage Oligomeric Matrix Protein Levels in Synovial Fluid in Patients With Primary Knee Osteoarthritis And Healthy Controls: A Preliminary Comparative Analysis With Serum Cartilage Oligomeric Matrix Protein [doi: 10.5606/ArchRheumatol.2017.6220] |
| Genetic Testing and Molecular Biomarkers | Cartilage Oligomeric Matrix Protein Levels in Type 2 Diabetes Associated with Primary Knee Osteoarthritis Patients [Pubmed: 30526057] |
| International Journal of Clinical and Experimental Medicine | The relationship between the serum and synovial fluid osteopontin (OPN), cartilage oligomeric matrix protein (COMP), and the severity of knee osteoarthritis … [] |
| British Journal of Medicine and Medical Research | Diagnostic Accuracy of Cartilage Oligomeric Matrix Protein (COMP), for Cartilage Damage in Rheumatoid Arthritis [] |
留言咨询